Showing 521 - 540 results of 743 for search '"chronic kidney disease"', query time: 0.12s Refine Results
  1. 521

    Correlation between Oxidative Stress and Thyroid Function in Patients with Nephrotic Syndrome by Sangita U. Sawant, Subhash Chandran, Alan F. Almeida, M. G. R. Rajan

    Published 2011-01-01
    “…Nephrotic syndrome is a form of chronic kidney disease due to which blood loses protein through the urine. …”
    Get full text
    Article
  2. 522

    Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy by Quan Zhuang, Ruoyu Ma, Yanshuang Yin, Tianhao Lan, Meng Yu, Yingzi Ming

    Published 2019-01-01
    “…Renal fibrosis, as the fundamental pathological process of chronic kidney disease (CKD), is a pathologic extension of the normal wound healing process characterized by endothelium injury, myofibroblast activation, macrophage migration, inflammatory signaling stimulation, matrix deposition, and remodelling. …”
    Get full text
    Article
  3. 523

    Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis by Melissa Sussman, Michael Epifania, Derrick Eng, Yun Jae Cho, Richard Steward

    Published 2021-01-01
    “…Herein, we describe a female patient with longstanding schizoaffective disorder and chronic kidney disease who suffered from clozapine-induced agranulocytosis after failing two other atypical antipsychotics. …”
    Get full text
    Article
  4. 524

    Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy by Esther Torrent, Marta Planellas, Laura Ordeix, Josep Pastor, Jaume Rodon, Laia Solano-Gallego

    Published 2018-01-01
    “…SDMA concentration ≥ 25 μg/dL was associated with clinical chronic kidney disease (CKD) after six months. Our results did not demonstrate advantages in using SDMA concentration as an early marker of CKD when compared to creatinine and UPC in canine leishmaniosis.…”
    Get full text
    Article
  5. 525
  6. 526

    Sepsis-Associated Acute Kidney Disease Incidence, Trajectory, and Outcomes by Hsiu-Yin Chiang, Chih-Chia Liang, Ya-Luan Hsiao, Uyen-Minh Le, Yi-Ching Chang, Pei-Shan Chen, David Ray Chang, I-Wen Ting, Hung-Chieh Yeh, Chin-Chi Kuo

    Published 2025-03-01
    “…This study aimed to use data algorithms on the electronic health records to trace the SA-AKD trajectory from acute kidney injury (AKI) to chronic kidney disease (CKD). Study Design: A retrospective cohort study. …”
    Get full text
    Article
  7. 527

    Estimated Glomerular Filtration Rate Correlates Poorly with Four-Hour Creatinine Clearance in Critically Ill Patients with Acute Kidney Injury by Christopher J. Kirwan, Barbara J. Philips, Iain A. M. MacPhee

    Published 2013-01-01
    “…None were near acceptable standards quoted in patients with chronic kidney disease (CKD). Conclusions. eGFR equations are not sufficiently accurate for use in critically ill patients with AKI. …”
    Get full text
    Article
  8. 528

    A Systematic Review and Meta-Analysis of Risk Factors Associated with Severity and Death in COVID-19 Patients by Pengqiang Du, Dandan Li, Aifeng Wang, Su Shen, Zhichao Ma, Xingang Li

    Published 2021-01-01
    “…Advanced age (≥65 years, severe illness, OR = 2.62; death, OR = 6.00), male (severe illness, OR = 1.49; death, OR = 1.54), chronic respiratory diseases (severe illness, OR = 5.67; death, OR = 3.72), diabetes (severe illness, OR = 3.27; death, OR = 2.60), hypertension (severe illness, OR = 3.08; death, OR = 3.53), chronic kidney disease (severe illness, OR = 3.59; death, OR = 5.38), and cardiovascular diseases (severe illness, OR = 3.87; death, OR = 4.91) were all risk factors. …”
    Get full text
    Article
  9. 529

    Renal Tissue-Derived Exosomal miRNA-34a in Diabetic Nephropathy Induces Renal Tubular Cell Fibrosis by Promoting the Polarization of M1 Macrophages by Shuai Zheng, Yi Zeng, Liqing Chu, Taiyang Gong, Sihong Li, Min Yang

    Published 2024-01-01
    “…Diabetic nephropathy (DN) is the leading cause of chronic kidney disease, and the activation and infiltration of phagocytes are critical steps of DN. …”
    Get full text
    Article
  10. 530

    Focal Segmental Glomerulosclerosis Preceding Type 2 Papillary Renal Cell Carcinoma by Dominik Dabrowski, Ekin Ozluk, Silvia Barbeito, Eric X. Wei

    Published 2020-01-01
    “…Here, we report a 58-year-old male with a past medical history of FSGS and chronic kidney disease (CKD), stage III, who was found to have an incidental renal mass that was later diagnosed as type II P-RCC. …”
    Get full text
    Article
  11. 531
  12. 532

    Physical activity and exercise recommendations for people receiving dialysis: A scoping review. by Kelly Lambert, Courtney J Lightfoot, Dev K Jegatheesan, Iwona Gabrys, Paul N Bennett

    Published 2022-01-01
    “…Key search terms included "kidney disease" OR "kidney failure" OR "chronic kidney disease" OR "end stage kidney disease" AND guideline* OR consensus OR "position statement" OR prescription OR statement AND exercise OR "physical activity". …”
    Get full text
    Article
  13. 533

    Рerioperative period of high-risk patients with coronary artery disease by O.K. Gogayeva

    Published 2021-07-01
    “…Among comorbid conditions, type 2 diabetes mellitus was diagnosed in 50 (25.7 %) patients, impaired glucose tolerance – in 82 (42.2 %) patients, obesity – in 74 (38.1 %) patients, 86 (44.3 %) patients were overweight with a body mass index 25–29.9 kg/m2, and 75 (38.6 %) patients were diagnosed with chronic kidney disease. According to coronary angiography, the average number of stenosed coronary arteries was 3.5. …”
    Get full text
    Article
  14. 534

    Comparison of creatinine‐based methods for estimating glomerular filtration rate in patients with heart failure by Anna Jonsson, Ida Viklund, Andreas Jonsson, Fredrik Valham, Ellinor Bergdahl, Krister Lindmark, Helena Norberg

    Published 2020-06-01
    “…Methods and results One hundred forty‐six HF patients (mean age 68 ± 13 years, mean left ventricular ejection fraction 45% ± 15) within a single‐centre hospital that underwent 51Cr‐EDTA clearance between 2010 and 2018 were included in this retrospective study. eGFR was estimated by means of Cockcroft–Gault ideal and actual weight, the Modification of Diet in Renal Disease Study (MDRD), simplified MDRD with isotope dilution mass spectroscopy traceable calibration, the Chronic Kidney Disease Epidemiology Collaboration, revised Lund–Malmö, full age spectrum, and the Berlin Initiative Study 1. …”
    Get full text
    Article
  15. 535

    Direct Medical Expenditures Associated with Eye Complications among Adults with Diabetes in the United States by Abdulkarim M. Meraya, Monira Alwhaibi, Moteb A. Khobrani, Hafiz A. Makeen, Saad S. Alqahtani, David Banji

    Published 2020-01-01
    “…After controlling for sex, age, race, poverty level, insurance coverage, prescription coverage, perceived physical and mental health, the number of chronic physical and mental conditions, marital status, education, the region of residence, smoking status, exercise, and chronic kidney disease (CKD), there was no difference in the out-of-pocket spending burden between adults with and those without ECs. …”
    Get full text
    Article
  16. 536
  17. 537

    Protective Effects of Tormentic Acid on Unilateral Ureteral Obstruction-Induced Renal Injury, Inflammation, and Fibrosis: A Comprehensive Approach to Reducing Oxidative Stress, Apo... by Ah Young Yang, Jung-Yeon Kim, Mi-Gyeong Gwon, Hyun Hee Kwon, Jaechan Leem, Eon-Ju Jeon

    Published 2024-12-01
    “…Chronic kidney disease (CKD) progresses through mechanisms involving inflammation, fibrosis, and oxidative stress, leading to the gradual structural and functional deterioration of the kidneys. …”
    Get full text
    Article
  18. 538

    Validation of the Kidney Failure Risk Equation in the Colombian Population by C. Larrarte, J. Vesga, F. Ardila, A. Aldana, D. Perea, M. Sanabria

    Published 2024-01-01
    “…Introduction. Chronic kidney disease prevention programs must identify patients at risk of early progression to provide better treatment and prolong kidney replacement therapy-free survival. …”
    Get full text
    Article
  19. 539

    Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel. by David E Henner, Beatrice Drambarean, Teresa M Gerbeling, Jessica B Kendrick, William T Kendrick, Lisa Koester-Wiedemann, Thomas L Nickolas, Anjay Rastogi, Anis A Rauf, Brenda Dyson, Michael C Singer, Pooja Desai, Kathleen M Fox, Sunfa Cheng, William Goodman

    Published 2025-01-01
    “…<h4>Background</h4>Secondary hyperparathyroidism (SHPT) is common in patients with chronic kidney disease (CKD). Many recommendations in the Kidney Disease Improving Global Outcomes (KDIGO) CKD-mineral and bone disorder guidelines are supported by modest evidence and predate the approval of newer agents. …”
    Get full text
    Article
  20. 540

    Factors Related to Significant Improvement of Estimated Glomerular Filtration Rates in Chronic Hepatitis B Patients Receiving Telbivudine Therapy by Te-Fu Lin, Ping-I Hsu, Kung-Hung Lin, Feng-Woei Tsay, Tzung-Jiun Tsai, Yan-Hua Chen, Hsien-Chung Yu

    Published 2017-01-01
    “…Serial eGFRs were calculated every 3 months using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. …”
    Get full text
    Article